BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8657493)

  • 21. Intravenous pulse methylprednisolone treatment of juvenile dermatomyositis.
    Laxer RM; Stein LD; Petty RE
    Arthritis Rheum; 1987 Mar; 30(3):328-34. PubMed ID: 3566824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure of pulse intravenous methylprednisolone treatment in juvenile dermatomyositis.
    Lang B; Dooley J
    J Pediatr; 1996 Mar; 128(3):429-32. PubMed ID: 8774518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sinus bradycardia after intravenous pulse methylprednisolone.
    Akikusa JD; Feldman BM; Gross GJ; Silverman ED; Schneider R
    Pediatrics; 2007 Mar; 119(3):e778-82. PubMed ID: 17308245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis.
    Huber AM; Lang B; LeBlanc CM; Birdi N; Bolaria RK; Malleson P; MacNeil I; Momy JA; Avery G; Feldman BM
    Arthritis Rheum; 2000 Mar; 43(3):541-9. PubMed ID: 10728746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of methylprednisolone and cyclophosphamide pulse therapy on renal infiltrating cells in patients with crescentic glomerulonephritis.
    Tang Z; Zhou H; Yao X; Hu W; Leishi L
    Chin Med J (Engl); 1997 Mar; 110(3):206-9. PubMed ID: 9594342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis.
    Riley P; McCann LJ; Maillard SM; Woo P; Murray KJ; Pilkington CA
    Rheumatology (Oxford); 2008 Jun; 47(6):877-80. PubMed ID: 18403404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pitfalls in treatment of acute cervical spinal cord injury using high-dose methylprednisolone: a retrospect audit of 111 patients.
    Lee HC; Cho DY; Lee WY; Chuang HC
    Surg Neurol; 2007; 68 Suppl 1():S37-41; discussion S41-2. PubMed ID: 17963919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulse intravenous methylprednisolone for resistant allergic bronchopulmonary aspergillosis in cystic fibrosis.
    Thomson JM; Wesley A; Byrnes CA; Nixon GM
    Pediatr Pulmonol; 2006 Feb; 41(2):164-70. PubMed ID: 16317722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis.
    Zivadinov R; Zorzon M; De Masi R; Nasuelli D; Cazzato G
    J Neurol Sci; 2008 Apr; 267(1-2):28-35. PubMed ID: 17945260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral mega pulse methylprednisolone in alopecia universalis.
    Bin Saif GA
    Saudi Med J; 2006 May; 27(5):717-20. PubMed ID: 16680269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment.
    Durez P; Nzeusseu Toukap A; Lauwerys BR; Manicourt DH; Verschueren P; Westhovens R; Devogelaer JP; Houssiau FA
    Ann Rheum Dis; 2004 Sep; 63(9):1069-74. PubMed ID: 15308515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Methylprednisolone pulse therapy for SLE patients with CNS disorder].
    Ichikawa Y; Hashimoto H; Kashiwazaki S; Kondo H; Akizuki M; Tokanou Y
    Ryumachi; 1994 Aug; 34(4):733-43. PubMed ID: 7974024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulse corticosteroid therapy for alopecia areata: study of 139 patients.
    Nakajima T; Inui S; Itami S
    Dermatology; 2007; 215(4):320-4. PubMed ID: 17911990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous methylprednisolone pulse therapy in essential mixed cryoglobulinemia nephropathy.
    De Vecchi A; Montagnino G; Pozzi C; Tarantino A; Locatelli F; Ponticelli C
    Clin Nephrol; 1983 May; 19(5):221-7. PubMed ID: 6851261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary analysis of a trial of pulse cyclophosphamide in IFN-beta-resistant active MS.
    Smith D
    J Neurol Sci; 2004 Aug; 223(1):73-9. PubMed ID: 15261565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment with megadoses of dexaven (dexamethasone) versus methypred (6-methylprednisolone) of patients with rheumatoid arthritis].
    Lashina NIu; Solov'ev SK; Balabanova RM
    Ter Arkh; 2000; 72(5):28-31. PubMed ID: 11109615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety.
    Al-Mayouf SM; Laxer RM; Schneider R; Silverman ED; Feldman BM
    J Rheumatol; 2000 Oct; 27(10):2498-503. PubMed ID: 11036850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Assessment on intermittent intravenous cyclophosphamide pulse therapy in diffuse proliferative lupus nephritis].
    Okubo T; Ideguchi H; Ihata A; Nakamura M; Ueda A; Ohno S; Hagiwara E; Aoki A; Shirai A; Ishigatsubo Y
    Ryumachi; 2000 Jun; 40(3):605-11. PubMed ID: 10920685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Methylprednisolone pulse therapy for a child with fulminant dermatomyositis].
    Mitsuda T; Yokota S; Mori T; Yoshida Y; Yoshida N; Kosuge K; Uechi M; Matsuyama S
    Ryumachi; 1987 Feb; 27(1):23-31. PubMed ID: 3660117
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.